EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

The Treatment of Refractory Vitiligo With Autologous Cultured Epithelium Grafting: A Real-World Retrospective Cohort Study

Jian Li, Xuanhao Zeng iD, Shujun Chen, Luyan Tang, Qi Zhang, Minzi Lv, Weiling Lian, Jinqi Wang, Haozhen Lv, Yating Liu, Jiayi Shen, Taro Uyama und 3 weitere

Stem Cells Translational Medicine · 2024

DOI: 10.1093/stcltm/szae009 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Stem Cells Translational Medicine, 2024. Verfasst von Jian Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Huashan Hospital of Fudan University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Vitiligo, Transplantation, Autologous. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Engineering Research Center of Hair Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Surgical intervention is the main therapy for refractory vitiligo. We developed a modified autologous cultured epithelial grafting (ACEG) technique for vitiligo treatment. Between January 2015 and June 2019, a total of 726 patients with vitiligo underwent ACEG in China, with patient characteristics and clinical factors being meticulously documented. Using a generalized linear mixed model, we were able to assess the association between these characteristics and the repigmentation rate.

Results

ACEG demonstrated a total efficacy rate of 82.81% (1754/2118) in treating 726 patients, with a higher repigmentation rate of 64.87% compared to conventional surgery at 52.69%. Notably, ACEG showed a better response in treating segmental vitiligo, lesions on lower limbs, age ≤ 18, and stable period > 3 years. A keratinocyte:melanocyte ratio below 25 was found to be advantageous too. Single-cell RNA sequencing analysis revealed an increase in melanocyte count and 2 subclusters of keratinocytes after ACEG, which remained higher in repigmented sites even after 1 year.

Conclusions

ACEG is a promising therapy for refractory vitiligo. Patient age, clinical type, lesion site, and stability before surgery influence repigmentation in ACEG. The mechanism of repigmentation after ACEG treatment is likely not confined to the restoration of melanocyte populations. It may also involve an increase in the number of keratinocytes that support melanocyte function within the affected area. These keratinocytes may aid the post-transplant survival and function of melanocytes by secreting cytokines and extracellular matrix components. Trial registration registered with Chictr.org.cn (ChiCTR2100051405).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoTransplantation, AutologousHumansMaleFemaleRetrospective StudiesAdultAdolescentYoung AdultMiddle AgedMelanocytesChildKeratinocytesCells, CulturedEpithelium

Stichwörter der Autor:innen

keratinocytemelanocytesingle-cell sequencingtransplantationvitiligo

Autor:innen und Institutionen

  • Department of Dermatology, Huashan Hospital of Fudan University, Shanghai, People's Republic of China.
  • Centre of Evidence Medicine, Fudan University, Shanghai, People's Republic of China.
  • Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
  • ReMed Regenerative Medicine Clinical Application Institute, Shanghai, People's Republic of China.
  • The Shanghai Institute of Dermatology, Shanghai, People's Republic of China.

ORCID-Profile: Xuanhao Zeng

Förderung

  • Shanghai Engineering Research Center of Hair Medicine
  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Zeng, X., Chen, S., Tang, L., Zhang, Q., Lv, M., Lian, W., Wang, J., Lv, H., Liu, Y., Shen, J., Uyama, T., Wu, F., Wu, J., & Xu, J. (2024). The Treatment of Refractory Vitiligo With Autologous Cultured Epithelium Grafting: A Real-World Retrospective Cohort Study. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szae009

Vancouver

Li J, Zeng X, Chen S, Tang L, Zhang Q, Lv M, et al. The Treatment of Refractory Vitiligo With Autologous Cultured Epithelium Grafting: A Real-World Retrospective Cohort Study. Stem Cells Translational Medicine. 2024. doi:10.1093/stcltm/szae009

BibTeX
@article{Li2024,
  author = {Li, Jian and Zeng, Xuanhao and Chen, Shujun and Tang, Luyan and Zhang, Qi and Lv, Minzi and Lian, Weiling and Wang, Jinqi and Lv, Haozhen and Liu, Yating and Shen, Jiayi and Uyama, Taro and Wu, Fuyue and Wu, Jinfeng and Xu, Jinhua},
  title = {The Treatment of Refractory Vitiligo With Autologous Cultured Epithelium Grafting: A Real-World Retrospective Cohort Study},
  journal = {Stem Cells Translational Medicine},
  year = {2024},
  doi = {10.1093/stcltm/szae009}
}
Kostenlos starten →